Medical cannabis formulation kills breast cancer cells in trial
June 28, 2021Sales and Marketing breast cancer, medical cannabis, oncology
UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
Tapeworm drug to be trialled nationally as COVID treatment
June 25, 2021Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm
Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …
Eli Lilly to seek FDA approval for experimental Alzheimer’s drug
June 25, 2021Medical Communications Alzheimer's, Eli Lilly, FDA
Eli Lilly plans to seek accelerated FDA approval for its experimental Alzheimer’s drug donanemab, announcing plans on Thursday to file …
Exscientia to collaborate with EQRx on drug development
June 25, 2021Medical Communications AI, Exscientia, clinical drug development
Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …
New test proven to detect over 50 types of cancer
June 25, 2021Medical Communications Cancer. test, US, oncology
Final results from a study into a new blood test that can detect more than 50 types of cancer have …
Sanofi’s NSCLC drug gains EC approval
June 25, 2021Medical Communications EC, EU, NSCLC, Sanofi
The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor, Libtayo (cemiplimab), for the first-line treatment of adults with …
Novartis announce digital collaboration with HPE
June 24, 2021AI, HPE, Novartis
Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …
Kite’s leukaemia cell therapy application validated by EMA
June 24, 2021EMA, Kite, leukemia
Kite has announced that their Type II variation application for a new indication to the approved license for autologous anti-CD19-transduced …
AstraZeneca’s Lynparza for prostate cancer approved in China
June 24, 2021AstraZeneca and MSD’s Lynparza has received conditional approval in China for the treatment of patients with BRCA-mutated metastatic castration-resistant prostate …
Survey reveals over 2 million people impacted by long COVID in UK
June 24, 2021COVID-19, UK, government, long covid, study
A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …
MHRA and EC approve Leo Pharma’s Adtralza for atopic dermatitis
June 24, 2021The MHRA and EC have approved Leo Pharma’s Adtralza (tralokinumab) for adults with moderate-to-severe atopic dermatitis who are candidates for …
Anti-parasitic drug investigated as potential COVID treatment
June 23, 2021Research and Development
The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …
AstraZeneca’s lung cancer treatment approved in China
June 23, 2021Research and Development
AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …
Extra 150 million doses of Moderna COVID jab bought by EC
June 23, 2021Research and Development
Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …
EU approves Janssen’s treatments for amyloidosis and multiple myeloma
June 23, 2021Research and Development
The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …
Vectura announces cannabinoid company collaboration for TBI treatment
June 23, 2021Research and Development
Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …
Biotage launches new automated platform for plasmid DNA purification
June 22, 2021Manufacturing and Production
Biotage has launched PhyPrep, a new automated platform for plasmid DNA purification. With the new Biotage PhyPrep platform, the automated …
Takeda collaboration to optimise biopharmaceutical manufacturing announced
June 22, 2021Manufacturing and Production Takeda, collaboration, manufacturing
A 36-month joint project between Takeda’s manufacturing site in Vienna, the Research Center Pharmaceutical Engineering (RCPE), InSilicoTrials, and the University …
LegoChem and Iksuda expand License Agreement for antibody drug conjugates
June 22, 2021Manufacturing and Production ADC, License Agreement, deal, technology
Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …
Insect-based vaccine production platform validated by EMA
June 22, 2021Manufacturing and Production Insect-based, Vaccine, production, technology
Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …
Latest content
